Drugs / Sulfur hexafluoride type-a lipid microspheres
Sulfur hexafluoride type-a lipid microspheres
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02786810 | Mar → Nov 2016 | urinary tract infection, vesicoureteral reflux | University of Tennessee | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sulfur hexafluoride type-a lipid microspheres | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02786810 ↗ |
| Modality | Diagnostic / imaging agent | “Used as a contrast to enhance renal ultrasound” NCT02786810 ↗ |
| Route | Intravenous | “0.03 ml/kg IV” NCT02786810 ↗ |